In Vitro Activities of Nine Antifungal Agents on Candida Species Isolated as Causative Agents from Clinical Materials
The incidence of mycotic infection due to yeasts has increased during the last few years because of the immunosuppressive therapies, prolonged antibiotic therapy, organ transplantations, aggressive instrumentations in medicine, AIDS, etc.
KeywordsCandida Albicans Antifungal Agent Candida Species Candida Tropicalis Throat Swab
Unable to display preview. Download preview PDF.
- 4.E.M. Johnson, M.D. Richard and D.N. Warnock, In vitro resistance to imidazole antifungals in Candida albicans, J. Antimicrob. Chemother., 13: 547 (1984).Google Scholar
- 5.R.F. Boyd and B.G. Hoerl, The pathogenic fungi, in “Basic Medi- cal Microbiology”, R.F. Boyd, ed., pp 775–813; Little, Brown and Company; Boston (1986).Google Scholar
- 6.P.D. Hoeprich and M.G. Rinaldi, Candidosis, in “Infectious Diseases”, P.D. Hoeprich, ed., pp 436–450, Harper and Row Publisher, Philadelphia (1983).Google Scholar
- 7.D. Kerridge and R.D. Nicholas, Drug resistance in the opportunistic pathogens Candida albicans and Candida glabrata, J.Antimicrob. Chemother., Supp. B, 18: 39 (1986).Google Scholar
- 8.M.R. Mc Ginnis and M.G. Rinaldi, Antifungal drugs: Mechanisms of action, drug resistance, susceptibility testing and assays of activity in biological fluids, in: “Antibiotics in Laboratory Medicine”, Second Edition, V. Lorian, ed., Williams and Wilkins, Baltimore (1986)Google Scholar
- 9.J.N. Galgiani, J. Reiser et al., Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods, Antimicrob. Agents Chemother., 31: 1343 (1987).Google Scholar
- 10.S.P. Clissold and J.V. Cutsem, Overview of the antimicrobial activity of ketoconazole, in: “Ketoconazole Today”, H.E. Jones, ed., pp. 1–18, ADIS Press Limited, Manchester (1987).Google Scholar
- 11.D.J. Drutz, Newer antifungal agents and their use, including an update on amphotericin B and flucytosine, in: “Current Clinical Topics in Infectious Disease”, J.S. Remington and M.N. Swartz, eds., pp 97–135, Mc Graw-Hill Book Company, New York (1982).Google Scholar
- 12.S.Shadomy and A. Espinel-Ingroff and R.Y. Cartwright, Laboratory studies with antifungal agents: Susceptibility test and bioassays, in: “Manual of Clinical Microbiology”, E.H. Lennette, ed., pp. 991–999, American Society for Microbiology, Washington D.C. (1985).Google Scholar